Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry

OBJECTIVES: The use of biologic and targeted synthetic (b/ts) DMARDs in the treatment of RA is increasing. Therefore, prevention of b/tsDMARDs-induced infection is important. Here we describe a prophylaxis protocol for preventing pneumocystis pneumonia (PCP) in RA patients treated with b/tsDMARDs. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonomoto, Koshiro, Tanaka, Hiroaki, Nguyen, Tuan Manh, Yoshinari, Hiroko, Nakano, Kazuhisa, Nakayamada, Shingo, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071566/
https://www.ncbi.nlm.nih.gov/pubmed/34382090
http://dx.doi.org/10.1093/rheumatology/keab647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071566/
https://www.ncbi.nlm.nih.gov/pubmed/34382090
http://dx.doi.org/10.1093/rheumatology/keab647

Ejemplares similares